- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00881829
Hypoxia Blood Validation in Multiple Pulse Oximeters
February 24, 2021 updated by: David Ransom, MD, Clinimark, LLC
Accuracy Validation in Multiple SpO2 Systems
The purpose of this study is to evaluate the SpO2 accuracy and performance of multiple pulse oximeters during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry for SpO2 validation.
This study is observational in nature which quantifies device performance and accuracy in comparison to a Reference Standard.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate the SpO2 accuracy and performance of pulse oximeters during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry for SpO2 validation.
The end goal is to show the SpO2 accuracy performance of the pulse oximeters.
It is expected that the Accuracy Root Mean Square (Arms) performance of pulse oximeters will meet a specification of 3 or better in non-motion conditions for the range of 70-100% SaO2 thereby demonstrating an acceptable SpO2 accuracy performance specification
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dena M Raley, BSBE
- Phone Number: 303-249-6010
- Email: DMRaley@Clinimark.com
Study Contact Backup
- Name: Paul B Batchelder, RRT
- Phone Number: 303-717-4820
- Email: PBatchelder@Clinimark.com
Study Locations
-
-
Colorado
-
Louisville, Colorado, United States, 80027
- Recruiting
- Clinimark Laboratories
-
Contact:
- Paul B Batchelder, RRT
- Phone Number: 303-717-4820
- Email: PBatchelder@Clinimark.com
-
Sub-Investigator:
- Paul B Batchelder, RRT, LRCP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Residents of the Denver metropolitan area.
Description
Inclusion Criteria:
- healthy individuals between the age of 18-50 years.
Exclusion Criteria:
- Clotting disorders, diabetes, currently taking psychotropic medications.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy volunteer
Smoker or non-smoker
|
Measurement of physiological parameters.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Completion of study by all subjects
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Ransom, MD, Avista Adventist Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 9, 2016
Primary Completion (ANTICIPATED)
December 21, 2021
Study Completion (ANTICIPATED)
December 21, 2021
Study Registration Dates
First Submitted
April 13, 2009
First Submitted That Met QC Criteria
April 14, 2009
First Posted (ESTIMATE)
April 15, 2009
Study Record Updates
Last Update Posted (ACTUAL)
February 26, 2021
Last Update Submitted That Met QC Criteria
February 24, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR 2016-192 Rev 1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxia
-
Western University, CanadaUnknownBrain Hypoxia IschemiaCanada
-
Yale UniversityTianjin Chest HospitalCompletedBrain Ischemia Hypoxia | Muscle; Ischemic | Muscle HypoxiaChina
-
Fliegerärztliches InstitutCompleted
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
Owlet Baby Care, Inc.Completed
-
Robert L. OwensCompletedIntermittent HypoxiaUnited States
-
University of Texas at AustinCompleted
-
Harbin Medical UniversityUnknown
-
University Hospital TuebingenUnknown
-
University Hospital, Strasbourg, FranceCompletedHypercapnia | Pulmonary Vascular Sensibility in Hypoxia | Hypoxia and HypercapniaFrance
Clinical Trials on Pulse Oximeter, Blood Pressure, Respiratory Rate, Respiratory Gasses, Temperature
-
Oxitone Medical Ltd.Clinimark, LLCCompleted
-
Rhythm Diagnostic SystemsClinimark, LLCActive, not recruiting
-
National Taiwan University HospitalRecruitingPain | Fatigue | Arthralgia | Myalgia | Fever | Headache | ChillsTaiwan
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingRespiratory Failure | Pneumonia, Bacterial | COVID-19 PneumoniaRussian Federation
-
Stanford UniversityWork of Breathing Study GroupCompletedAsthma | Copd | Respiratory Effort | Contactless Vital Sign MonitoringUnited States
-
Xim LimitedUniversity of PortsmouthCompletedVital SignsUnited Kingdom
-
Vanderbilt-Ingram Cancer CenterKite, A Gilead CompanyActive, not recruitingDiffuse Large B-cell Lymphoma | Large B-cell LymphomaUnited States
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted